Clinical trials: Bacterial Enteritis
Bacterial Enteritis
A Phase 1,Open -Label Study to Assess the Absorption, Metabolism and Excretion of 14C-OPS-2071 Following a Single Oral Dose to Healthy Male Japanese Subjects
To obtain absorption, metabolism and excretion data for parent drug and any metabolites.
- Trial name
- NCT02440633
- Testing
- 14C-OPS-2071
- Where
- United Kingdom
- Volunteers
- 8 people, healthy volunteers welcome
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
Bacterial Enteritis
A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
To assess safety, efficacy and pharmacokinetics of multiple dosesin patients with Bacterial Enteritis caused by Clostridium difficile infection(CDI) or Enteric infection.
- Trial name
- NCT02473393
- Testing
- OPS-2071 tablet
- Where
- 3 sites in Japan, Singapore and 1 more
- Volunteers
- 43 people
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.